OncLivePositive Idelalisib Data Halts Late-Stage CLL TrialOncLiveA phase III study of the PI3K-delta inhibitor idelalisib in combination with rituximab (Rituxan) has been stopped early following a positive interim analysis, according to a statement fro…
|
A+E calendar: James Patterson, Haunted Graveyard in Bristol, Branford foliage …
New Haven Register Danbury: Aaron and Andrew, 9 p.m. Oct. 17, WCSU Midtown Coffeehouse, free, donations accepted, Western Connecticut State University, 181 White St., 203-837-8486. Deep River: Connecticut Gilbert and Sullivan Society presents “The … New Haven: Governor … |
Lineage, Location and Kidney TransplantsdailyRxPatients have two options when their kidneys fail: dialysis or kidney transplantation. Until a patient can get a new kidney, they have to be on dialysis, a process that replaces the normal function of kidn…
Geographic location may help explain why Hispanics face disparities in kidney …Medical XpressIn the United States, Hispanics with kidney failure are less likely than non-Hispanic whites to receive a kidney transplant largely due to their blood type a…
Website clears doubts on organ, body donationTimes of IndiaBELGAUM: Here is a website for a cause. Dr Ramannavar Charitable Trust, headed by ayurveda doctor and anatomy lecturer Dr Mahantesh Ramannavar, has launched a website to create awareness on org…
OncLiveNo Age Limit for Bone Marrow TransplantationOncLiveAge is no longer a consideration when determining whether an older patient with blood cancer is a candidate for stem cell transplantation. That was the conclusion two years ago of the first stud…
Idelalisib works against leukemia, trial stopped earlyCuretoday.com (press release)The phase 3 trial compared treatment with idelalisib and another drug, Rituxan (rituximab), to treatment with Rituxan alone in patients with CLL who were not eligible fo…
New York Times (blog)Living With Cancer: Hospital CityNew York Times (blog)Tracheostomy, nephrectomy, thoracotomy, colostomy, splenectomy, urostomy, craniotomy, embolectomy, ileostomy, cystostomy, cystectomy, gastrectomy, hepatectomy, prostatectomy, lo…
|
Gilead Stops Pivotal Trial Early as New Leukemia Drug Demonstrates Strong …
Equities.com The monitoring committee made its recommendation based upon a predefined protocol showing “highly statistically significant efficacy” for the primary endpoint of progression-free survival in patients receiving a cocktail of idelalisib and rituximab … |
|
FDA To Hold Public Teleconference on October 16 on Myalgic …
Sacramento Bee Rituximab is also showing promise in trials of ME/CFS patients. “The researchers and clinical experts involved in these studies are some of the top ME/CFS experts in the world and have the experience to know what outcome measures are best for ME/CFS … |